Dr. Priya Nair
MD
PhD
FACP
Associate Professor of Oncology
Dana-Farber Cancer Institute
Computational Oncology & Precision Medicine
Verified By
AIMWELLBIO
Decision Intelligence
Verified Contributor
TIER III
Emerging Authority
VERIFIED ON
May 14, 2024
6
Publications1,847
Citations8
Clinical Trials12
CollaborationsAbout Dr. Priya Nair
Dr. Nair leads translational research at the intersection of AI and oncology, focusing on tumor microenvironment profiling and biomarker-driven treatment selection. Her work spans SEER cohort analyses, NCI-funded RCTs, and multi-institutional collaboration networks across 12 countries.
Show more →Share Your Profile
Showcase your verified contributions to evidence-backed decision intelligence.
Verified AimwellBio Contributor
Evidence. Intelligence. Impact.
Public Profile
aimwell.bio/contributor/priya-nair
Evidence-Based
Verified contributions to real-world intelligence
Peer-Acknowledged
Reviewed by the AimwellBio validation layer
Global Impact
Supporting better decisions in healthcare
Trusted Network
Part of a curated network of expert contributors
Selected Publications
View all 6 publications on PubMed ↗AI-driven tumor microenvironment profiling improves immunotherapy response prediction
Journal of Clinical Oncology
2023 · 41(7) · 1123–1134
High ImpactCited by 312
Multi-omics integration identifies novel biomarkers for treatment stratification in NSCLC
Nature Communications
2022 · 13(1) · 2456
High ImpactCited by 286
Real-world evidence of biomarker-guided therapy in metastatic colorectal cancer
Clinical Cancer Research
2021 · 27(15) · 3987–3996
High ImpactCited by 241
Academic Links
Contribution Focus
- Oncology signal evaluation
- AI/ML in drug discovery
- Biomarker & signature validation
- Clinical trial design & analytics
- Real-world evidence generation
Request Collaboration
Invite Dr. Nair to contribute to your intelligence project or advisory effort.
Trusted. Verified. Making an Impact.
AimwellBio contributors are the foundation of better decisions.
